Apathy is Associated with Critical Psychological Determinants of Medication Adherence in HIV Disease

被引:15
作者
Babicz, Michelle A. [1 ]
Woods, Steven Paul [1 ]
Fazeli, Pariya [2 ]
Morgan, Erin E. [3 ]
机构
[1] Univ Houston, Dept Psychol, 126 Heyne Bldg,Suite 204, Houston, TX 77004 USA
[2] Univ Alabama Birmingham, Sch Nursing, Birmingham, AL USA
[3] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA
关键词
HIV; AIDS; Apathy; Motivation; Neuropsychiatry; Medication adherence; QUALITY-OF-LIFE; COGNITIVE PERFORMANCE; BRAIN-INJURY; VALIDITY; DEPRESSION; SYMPTOMS; THERAPY; IMPAIRMENT; DISORDERS; EFFICACY;
D O I
10.1007/s10880-020-09715-7
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Apathy is common in HIV, separable from depression, and has been associated with non-adherence to antiretroviral therapy (ART). We examined the associations between apathy and critical psychological determinants of ART adherence, as per the information-motivation-behavioral model, in 85 persons living with HIV. Apathy was measured using a composite of the apathy subscale of the Frontal Systems Behavioral Scale and the vigor-activation scale of the Profile of Mood States. Independent of major depressive disorder, apathy was related at small-to-medium effect sizes with motivation to adhere and self-efficacy for health-related decision-making and medication management, but not with HIV knowledge or medication management skills. These findings suggest that apathy plays a unique role in several critical health adherence determinants and support the importance of assessment and management of apathy to maximize health outcomes among individuals with HIV disease.
引用
收藏
页码:301 / 312
页数:12
相关论文
共 67 条
  • [1] American Psychiatric Association, 2015, DEPR DIS DSM 5 SEL
  • [2] [Anonymous], 1981, Profile of mood states: Manual
  • [3] The role of the dorsal striatum in reward and decision-making
    Balleine, Bernard W.
    Delgado, Mauricio R.
    Hikosaka, Okihide
    [J]. JOURNAL OF NEUROSCIENCE, 2007, 27 (31) : 8161 - 8165
  • [4] Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status
    Barclay, Terry R.
    Hinkin, Charles H.
    Castellon, Steven A.
    Mason, Karen I.
    Reinhard, Matthew J.
    Marion, Sarah D.
    Levine, Andrew J.
    Durvasula, Ramani S.
    [J]. HEALTH PSYCHOLOGY, 2007, 26 (01) : 40 - 49
  • [5] Double-blind, placebo-controlled, multicenter trial of selegiline augmentation of antipsychotic medication to treat negative symptoms in outpatients with schizophrenia
    Bodkin, JA
    Siris, SG
    Bermanzohn, PC
    Hennen, J
    Cole, JO
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2005, 162 (02) : 388 - 390
  • [6] Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection
    Carey, CL
    Woods, SP
    Gonzalez, R
    Conover, E
    Marcotte, TD
    Grant, I
    Heaton, RK
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY, 2004, 26 (03) : 307 - 319
  • [7] Development and psychometric evaluation of the brief HIV knowledge questionnaire
    Carey, MP
    Schroder, KEE
    [J]. AIDS EDUCATION AND PREVENTION, 2002, 14 (02) : 172 - 182
  • [8] Apathy, depression, and cognitive performance in HIV-1 infection
    Castellon, SA
    Hinkin, CH
    Wood, S
    Yarema, KT
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1998, 10 (03) : 320 - 329
  • [9] Are the available apathy measures reliable and valid? A review of the psychometric evidence
    Clarke, Diana E.
    Ko, Jean Y.
    Kuhl, Emily A.
    van Reekum, Robert
    Salvador, Rocio
    Marin, Robert S.
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2011, 70 (01) : 73 - 97
  • [10] PHYSICIANS CHARACTERISTICS INFLUENCE PATIENTS ADHERENCE TO MEDICAL-TREATMENT - RESULTS FROM THE MEDICAL OUTCOMES STUDY
    DIMATTEO, MR
    SHERBOURNE, CD
    HAYS, RD
    ORDWAY, L
    KRAVITZ, RL
    MCGLYNN, EA
    KAPLAN, S
    ROGERS, WH
    [J]. HEALTH PSYCHOLOGY, 1993, 12 (02) : 93 - 102